STOCK TITAN

Modular Medical (MODD) Stock News

MODD NASDAQ

Modular Medical, Inc. reports developments tied to its diabetes-focused medical device business and its Pivot tubeless insulin patch pump. The company is a development-stage insulin delivery technology company using patented technologies to support insulin pump adoption among people with diabetes. Pivot is described as a two-part tubeless patch pump with a removable 3 mL reservoir, disposable battery, and smartphone connectivity for bolus and monitoring.

Recurring MODD news includes FDA 510(k) clearance for Pivot, manufacturing validation, commercial-readiness updates, investor presentations, Nasdaq listing compliance, reverse stock split actions, shareholder voting matters, capital-structure disclosures, governance updates, and operating and financial results.

Rhea-AI Summary

Modular Medical (NASDAQ:MODD) completed a patient market research study with Thrivable evaluating perceptions of its Pivot tubeless insulin delivery system. The multi-phase study included more than 540 participants with Type 1 or Type 2 diabetes, including injection users and people who had transitioned to pumps.

Among more than 300 multiple daily injection users, approximately nine out of 10 would consider a simpler insulin delivery option. Lower cost (59.7%) and reduced effort (57.4%) were the most important factors motivating consideration of an alternative. In the broader survey, 57.8% of Type 2 respondents and 38.9% of Type 1 respondents reported favorable perceptions of Pivot. These findings describe patient attitudes, rather than clinical outcomes. Modular Medical said the insights will guide patient engagement, education and commercialization planning as it prepares for Pivot's full commercial launch.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
39.10%
Tags
none
-
Rhea-AI Summary

Modular Medical (NASDAQ:MODD) received a positive notified body decision regarding certification of its medical device quality management system under ISO 13485:2016.

The standard covers quality management systems for medical devices, with certification demonstrating conformity through an independent audit within the certification's scope. The notified body is designated under the European Union Medical Device Regulation. Modular Medical continues to target calendar year 2027 for its CE Mark submission. ISO certification is separate from CE marking, which requires additional regulatory review. A CE mark, if obtained, would allow the company to pursue EU commercial distribution, subject to applicable regulatory and operational criteria.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
-
Rhea-AI Summary

Modular Medical (MODD) launched two digital education resources to familiarize prospective users with its Pivot insulin delivery system before formal training. Developed with Relevate Health Games, the tools include a virtual walkthrough and a Pivot module within Level One: A Diabetes Game. The company is preparing for Pivot's full commercial launch.

The approximately 15-minute walkthrough covers unpacking, preparing and applying the pump, plus basic operation. It is optional and is not part of Pivot's FDA-required training program. The Level One module introduces the pump within mealtime insulin education; it does not provide individualized dosing recommendations or replace professional guidance. Modular Medical believes the resources can support patient confidence, adoption and retention.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.77%
Tags
none
Rhea-AI Summary

Modular Medical (NASDAQ:MODD) will present at the Webull Emerging & Innovative Companies Webinar on October 14, 2026. Chief Executive Officer Jeb Besser will give the presentation at 1:00 p.m. ET. A webcast will be available through the company's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.56%
Tags
none
-
Rhea-AI Summary

Modular Medical (MODD) announced a contract with a national U.S. pharmacy benefit manager (PBM), making its Pivot™ tubeless patch pump insulin delivery system available through that PBM.

The company views this agreement, which it says is with one of the largest PBMs in the country, as a key commercialization milestone that can broaden patient access and support validation of Pivot as an accessible diabetes therapy option. PBMs manage prescription drug benefits and formulary placement for health plans and employers, helping reduce barriers to access and streamline reimbursement. Pivot is a wearable, three-day tubeless patch pump designed to transition patients from multiple daily injections to continuous insulin infusion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.60%
Tags
none
-
Rhea-AI Summary

Modular Medical (MODD) received FDA clearance for software enhancements to its Pivot tubeless insulin patch pump system, expanding functionality ahead of its planned fourth quarter 2026 commercial launch.

The clearance covers upgrades that provide greater flexibility and customization in bolus dosing, an enhanced user interface, and other software improvements. The company said these are the first in a series of planned enhancements to the Pivot platform, including the ability to customize the amount of insulin delivered with each button press. Pivot is designed as a simple, wearable insulin delivery system providing continuous basal and bolus insulin over a three-day wear period, with the aim of offering an accessible alternative to multiple daily injections for a broader diabetes population.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
Rhea-AI Summary

Modular Medical (MODD) announced that CEO Jeb Besser will present at Tribe Public's CEO Presentation and Q&A webinar titled "The Road To Revenue: Modular Medical's Strategy For Launching Pivot" on Friday, September 4, 2026 at 8:30 a.m. Pacific / 11:30 a.m. Eastern.

The complimentary event is hosted by Tribe Public's Managing Member, John F. Heerdink, Jr., who will relay participant questions to management. Interested attendees can register at PivotLaunch.TribePublic.com, after which they may submit questions in advance via email to research@tribepublic.com or during the session through the Zoom chat feature.

The webinar will focus on Modular Medical's Pivot™ tubeless patch pump, a simple, wearable insulin delivery platform designed for continuous subcutaneous insulin infusion with basal and bolus delivery over a three-day wear period. The system is intended to provide an accessible pathway from multiple daily injections to insulin pump therapy for insulin-dependent adults, addressing what the company describes as a multi-billion-dollar market opportunity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
none
-
Rhea-AI Summary

Modular Medical (NASDAQ: MODD) will participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference in Columbus, Ohio, from August 7-10, 2026. Management will host booth #1516 to showcase live demonstrations of its Pivot™ tubeless insulin patch pump ahead of an October launch in five U.S. markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.94%
Tags
none
-
Rhea-AI Summary

Modular Medical (NASDAQ: MODD) announced it will begin the first phase of full commercial launch of its Pivot™ tubeless patch insulin pump in October 2026, targeting five U.S. markets: Atlanta, Cincinnati/Lexington, Dallas, Houston, and Philadelphia. This initial rollout is described as a capital-efficient step focused on regions with high insulin pump prescribing activity and large populations of patients using multiple daily injections (MDI), Pivot’s primary target group.

According to the company, these markets account for 14% of the nation’s highest-volume insulin pump prescribers, 15% of all new insulin pump starts, and 21% of prescribers with high affinity for new brand adoption for MDI patients, based on PurpleLab® data for the 24 months ended June 2025. Modular Medical has also partnered with Inizio, a global healthcare commercialization firm, to provide commercial execution, provider engagement, and launch support aimed at accelerating awareness and adoption of the Pivot pump in initial and future markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.11%
Tags
none
Rhea-AI Summary

Modular Medical (NASDAQ:MODD) announced the formation of the Pivot Innovation Council, a cross-functional group of clinicians and healthcare experts created to guide clinical and commercial strategy for its Pivot™ tubeless patch pump. Diabetes care leader Robert Gabbay, MD, PhD, FACP has been appointed chairman.

The council will advise on target patient populations, workflow integration, evidence-generation initiatives, and the Pivot product roadmap and go-to-market approach. According to Modular Medical, Dr. Gabbay’s extensive background in diabetes care transformation, population health, and patient-centered care will support efforts to expand clinical evidence, strengthen provider engagement, and improve access to simpler insulin pump therapy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.70%
Tags
none

FAQ

What is the current stock price of Modular Medical (MODD)?

Modular Medical (MODD) last closed at $1.91.

What is the market cap of Modular Medical (MODD)?

The market cap of Modular Medical (MODD) is approximately $18.1M.